Nabriva Therapeutics AG Price Prediction
| NBRVDelisted Stock | USD 1.62 0.01 0.61% |
Oversold Vs Overbought
51
Oversold | Overbought |
Using Nabriva Therapeutics hype-based prediction, you can estimate the value of Nabriva Therapeutics AG from the perspective of Nabriva Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nabriva Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nabriva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nabriva Therapeutics after-hype prediction price | USD 1.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nabriva |
Nabriva Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Nabriva Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nabriva Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nabriva Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nabriva Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nabriva Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nabriva Therapeutics' historical news coverage. Nabriva Therapeutics' after-hype downside and upside margins for the prediction period are 1.62 and 1.62, respectively. We have considered Nabriva Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nabriva Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Nabriva Therapeutics is based on 3 months time horizon.
Nabriva Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nabriva Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nabriva Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nabriva Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.62 | 1.62 | 0.00 |
|
Nabriva Therapeutics Hype Timeline
Nabriva Therapeutics is now traded for 1.62. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nabriva is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Nabriva Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 1.62. The company has price-to-book ratio of 0.24. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nabriva Therapeutics recorded a loss per share of 19.67. The entity last dividend was issued on the 3rd of December 2020. The firm had 1:25 split on the 16th of September 2022. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.Nabriva Therapeutics Related Hype Analysis
Having access to credible news sources related to Nabriva Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nabriva Therapeutics' future price movements. Getting to know how Nabriva Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nabriva Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EVOK | Evoke Pharma | (0.09) | 9 per month | 4.82 | 0.03 | 7.55 | (7.18) | 48.38 | |
| TRVN | Trevena | (0.51) | 7 per month | 0.00 | (0.06) | 20.99 | (15.37) | 99.50 | |
| DFFN | Diffusion Pharmaceuticals | 0.1 | 5 per month | 0.00 | (0.20) | 4.09 | (5.32) | 12.34 | |
| PRTK | Paratek Pharmaceuticals | 0.05 | 2 per month | 5.20 | (0.01) | 10.13 | (6.97) | 35.80 | |
| CLSD | Clearside Biomedical | 0.01 | 9 per month | 0.00 | (0.06) | 8.97 | (6.72) | 24.63 |
Nabriva Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nabriva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nabriva using various technical indicators. When you analyze Nabriva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nabriva Therapeutics Predictive Indicators
The successful prediction of Nabriva Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nabriva Therapeutics AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nabriva Therapeutics based on analysis of Nabriva Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nabriva Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nabriva Therapeutics's related companies.
Story Coverage note for Nabriva Therapeutics
The number of cover stories for Nabriva Therapeutics depends on current market conditions and Nabriva Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nabriva Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nabriva Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nabriva Therapeutics Short Properties
Nabriva Therapeutics' future price predictability will typically decrease when Nabriva Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nabriva Therapeutics AG often depends not only on the future outlook of the potential Nabriva Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nabriva Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.7 M | |
| Cash And Short Term Investments | 12.4 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Nabriva Stock
If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |